Selected research
Market Structure
Global Sodium Glucuronic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sodium Glucuronic Acid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sodium Glucuronic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sodium Glucuronic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sodium Glucuronic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sodium Glucuronic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sodium Glucuronic Acid include Pai Gurosan injections, RPI, Chengdu Tiantai Mount Pharmaceutical, DongYao, Quanxing pharmaceutical and Kanglang Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sodium Glucuronic Acid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sodium Glucuronic Acid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sodium Glucuronic Acid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Glucuronic Acid market size, projected growth trends, production technologies, key applications, and end-use industries.
Sodium Glucuronic Acid Segment by Company
Pai Gurosan injections
RPI
Chengdu Tiantai Mount Pharmaceutical
DongYao
Quanxing pharmaceutical
Kanglang Biotechnology
Sodium Glucuronic Acid Segment by Type
Intravenous Injection Type
Intravenous Drip Type
Sodium Glucuronic Acid Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
Sodium Glucuronic Acid Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Glucuronic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sodium Glucuronic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Glucuronic Acid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sodium Glucuronic Acid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sodium Glucuronic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sodium Glucuronic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sodium Glucuronic Acid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous Injection Type
- Intravenous Drip Type
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Others
Companies covered
- Pai Gurosan injections
- RPI
- Chengdu Tiantai Mount Pharmaceutical
- DongYao
- Quanxing pharmaceutical
- Kanglang Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sodium Glucuronic Acid Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sodium Glucuronic Acid Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sodium Glucuronic Acid Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sodium Glucuronic Acid Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sodium Glucuronic Acid Market Dynamics
- 2.1 Sodium Glucuronic Acid Industry Trends
- 2.2 Sodium Glucuronic Acid Industry Drivers
- 2.3 Sodium Glucuronic Acid Industry Opportunities and Challenges
- 2.4 Sodium Glucuronic Acid Industry Restraints
3 Sodium Glucuronic Acid Market by Manufacturers
- 3.1 Global Sodium Glucuronic Acid Revenue by Manufacturers (2021-2026)
- 3.2 Global Sodium Glucuronic Acid Sales by Manufacturers (2021-2026)
- 3.3 Global Sodium Glucuronic Acid Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sodium Glucuronic Acid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sodium Glucuronic Acid Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sodium Glucuronic Acid Manufacturers, Product Type & Application
- 3.7 Global Sodium Glucuronic Acid Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sodium Glucuronic Acid Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sodium Glucuronic Acid Players Market Share by Revenue in 2025
- 3.8.3 2025 Sodium Glucuronic Acid Tier 1, Tier 2, and Tier 3
4 Sodium Glucuronic Acid Market by Type
- 4.1 Sodium Glucuronic Acid Type Introduction
- 4.1.1 Intravenous Injection Type
- 4.1.2 Intravenous Drip Type
- 4.2 Global Sodium Glucuronic Acid Sales by Type
- 4.2.1 Global Sodium Glucuronic Acid Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sodium Glucuronic Acid Sales by Type (2021-2032)
- 4.2.3 Global Sodium Glucuronic Acid Sales Market Share by Type (2021-2032)
- 4.3 Global Sodium Glucuronic Acid Revenue by Type
- 4.3.1 Global Sodium Glucuronic Acid Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sodium Glucuronic Acid Revenue by Type (2021-2032)
- 4.3.3 Global Sodium Glucuronic Acid Revenue Market Share by Type (2021-2032)
5 Sodium Glucuronic Acid Market by Application
- 5.1 Sodium Glucuronic Acid Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Sodium Glucuronic Acid Sales by Application
- 5.2.1 Global Sodium Glucuronic Acid Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sodium Glucuronic Acid Sales by Application (2021-2032)
- 5.2.3 Global Sodium Glucuronic Acid Sales Market Share by Application (2021-2032)
- 5.3 Global Sodium Glucuronic Acid Revenue by Application
- 5.3.1 Global Sodium Glucuronic Acid Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sodium Glucuronic Acid Revenue by Application (2021-2032)
- 5.3.3 Global Sodium Glucuronic Acid Revenue Market Share by Application (2021-2032)
6 Global Sodium Glucuronic Acid Sales by Region
- 6.1 Global Sodium Glucuronic Acid Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sodium Glucuronic Acid Sales by Region (2021-2032)
- 6.2.1 Global Sodium Glucuronic Acid Sales by Region (2021-2026)
- 6.2.2 Global Sodium Glucuronic Acid Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sodium Glucuronic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sodium Glucuronic Acid Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sodium Glucuronic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sodium Glucuronic Acid Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sodium Glucuronic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sodium Glucuronic Acid Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sodium Glucuronic Acid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sodium Glucuronic Acid Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sodium Glucuronic Acid Revenue by Region
- 7.1 Global Sodium Glucuronic Acid Revenue by Region
- 7.1.1 Global Sodium Glucuronic Acid Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sodium Glucuronic Acid Revenue by Region (2021-2026)
- 7.1.3 Global Sodium Glucuronic Acid Revenue by Region (2027-2032)
- 7.1.4 Global Sodium Glucuronic Acid Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sodium Glucuronic Acid Revenue (2021-2032)
- 7.2.2 North America Sodium Glucuronic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sodium Glucuronic Acid Revenue (2021-2032)
- 7.3.2 Europe Sodium Glucuronic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sodium Glucuronic Acid Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sodium Glucuronic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sodium Glucuronic Acid Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sodium Glucuronic Acid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pai Gurosan injections
- 8.1.1 Pai Gurosan injections Company Information
- 8.1.2 Pai Gurosan injections Business Overview
- 8.1.3 Pai Gurosan injections Sodium Glucuronic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pai Gurosan injections Sodium Glucuronic Acid Product Portfolio
- 8.1.5 Pai Gurosan injections Recent Developments
- 8.2 RPI
- 8.2.1 RPI Company Information
- 8.2.2 RPI Business Overview
- 8.2.3 RPI Sodium Glucuronic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 RPI Sodium Glucuronic Acid Product Portfolio
- 8.2.5 RPI Recent Developments
- 8.3 Chengdu Tiantai Mount Pharmaceutical
- 8.3.1 Chengdu Tiantai Mount Pharmaceutical Company Information
- 8.3.2 Chengdu Tiantai Mount Pharmaceutical Business Overview
- 8.3.3 Chengdu Tiantai Mount Pharmaceutical Sodium Glucuronic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chengdu Tiantai Mount Pharmaceutical Sodium Glucuronic Acid Product Portfolio
- 8.3.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
- 8.4 DongYao
- 8.4.1 DongYao Company Information
- 8.4.2 DongYao Business Overview
- 8.4.3 DongYao Sodium Glucuronic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 DongYao Sodium Glucuronic Acid Product Portfolio
- 8.4.5 DongYao Recent Developments
- 8.5 Quanxing pharmaceutical
- 8.5.1 Quanxing pharmaceutical Company Information
- 8.5.2 Quanxing pharmaceutical Business Overview
- 8.5.3 Quanxing pharmaceutical Sodium Glucuronic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Quanxing pharmaceutical Sodium Glucuronic Acid Product Portfolio
- 8.5.5 Quanxing pharmaceutical Recent Developments
- 8.6 Kanglang Biotechnology
- 8.6.1 Kanglang Biotechnology Company Information
- 8.6.2 Kanglang Biotechnology Business Overview
- 8.6.3 Kanglang Biotechnology Sodium Glucuronic Acid Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Kanglang Biotechnology Sodium Glucuronic Acid Product Portfolio
- 8.6.5 Kanglang Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sodium Glucuronic Acid Value Chain Analysis
- 9.1.1 Sodium Glucuronic Acid Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sodium Glucuronic Acid Production Mode & Process
- 9.2 Sodium Glucuronic Acid Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sodium Glucuronic Acid Distributors
- 9.2.3 Sodium Glucuronic Acid Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst